|
Centre for Policy on Ageing | |
 | |
|
Alzheimer disease ethics - informed consent and related issues in clinical trials results of a survey among the members of the Research Ethics Committees in Sweden | Author(s) | Gunbrith Peterson, Anders Wallin |
Journal title | International Psychogeriatrics, vol 15, no 2, June 2003 |
Pages | pp 157-170 |
Keywords | Dementia ; Social ethics ; Attitude ; Therapeutics ; Research ; Social surveys ; Sweden. |
Annotation | The rapid advances in biomedical sciences have induced special moral and ethical attitudes, which should be taken into account. One of the most essential issues is the principles for participation in research of subjects with reduced decision-making capacity. The authors conducted a questionnaire survey among members of the research ethics committees in Sweden, to find out their attitudes to a range of ethical issues related to research on people with Alzheimer's disease (AD). 136 of those approached responded (66%); 117 responses (56%) were considered complete. With a few exceptions, there were no significant differences in attitudes between experts and laypersons, between people of different ages, and between men and women. However, women and laypersons were generally keener to preserve the patient's integrity, while the experts were more willing than laypersons to allow subjects with dementia to participate in placebo-controlled trials. (RH). |
Accession Number | CPA-031212201 A |
Classmark | EA: TQ: DP: LL: 3A: 3F: 76P |
Data © Centre for Policy on Ageing |
|
...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|